We market well.

Your agency should fully understand your product and the science. Then, there’s the marketplace. Grasping all three dynamics is a specialized field. Ours.

Our philosophy implies there are no excuses for boring and dull. The medical industry deserves better.

Spread the word. Big or small. Any time, any place. Right now, today. Don’t wait, hesitate or ruminate. We can help all medical companies. We’d like to make your brand our next success story.

A CASE STUDY CLICK HERE
to review a copy of the book
NOW IN PROGRESS
World’s 2nd most popular
search engine? YouTube.

People are naturally interested in other humans and information.
Attract, educate and engage with videos that tell your story—just keep it brief.
SEE MORE
recent work right here
The Medical News
Japan found African swine fever in packed pork sausage being carried into the country by a foreigner coming from Beijing early this month, the nation's agriculture ministry said on Tuesday.... AstraZeneca is plowing deeper into cancer immunotherapy through a wide-ranging deal with Innate Pharma, which includes the British group buying a 9.8 percent stake in the French biotech company.... Canada's FSD Pharma Inc signed a letter of intent to acquire Israel's Therapix Biosciences Ltd for $48 million in stock, combining two complementary businesses focused on the research and development of cannabinoid treatments.... Drugmaker Idorsia is confident its cash reserves are large enough to complete development of its late-stage pipeline, it said on Tuesday, despite losing more than a quarter of a billion Swiss francs in the first nine months of the year.... China's agriculture ministry on Tuesday said two new cases of African swine fever had been confirmed in the central province of Hunan.... (Reuters Health) - The popular e-cigarette brand JUUL is attracting an alarming number of teens online, researchers say. At least a quarter of JUUL's twitter followers may be under 18, they write in the Journal of Adolescent Health.... (Reuters Health) - Kids who are obese may be more likely to develop a severe hip disorder than children who are not overweight, a UK study suggests.... (Reuters Health) - When getting their infants vaccinated, mothers were more likely to use proven techniques to ease babies' pain if they had been taught how to do so before taking their newborns home from the hospital, a study found.... Marlboro cigarette maker Philip Morris International drew accusations of hypocrisy on Monday after using a four-page newspaper advertisement to urge smokers to quit cigarettes.... (Reuters Health) - People who eat more organic foods may be slightly less likely to develop certain cancers, a French study suggests.... Kellogg Co said on Monday it would bring back Honey Smacks cereal on U.S. retailer shelves in November, months after it pulled the product due to a Salmonella scare.... U.S. hog farmers are ramping up safety procedures and leaving animal-feed ingredients imported from China in storage in an attempt to keep out a highly contagious swine disease that is sweeping through Asia and Europe.... China's three-month old outbreak of African swine fever has spread for the first time to the country's south, its major pork-consuming region, signaling how deeply the deadly disease has permeated the country's pig herd, the world's largest.... Roche's Tecentriq plus chemotherapy boosted lung cancer patients' survival by nearly five months, study data released on Monday showed, underscoring benefits of the Swiss group's immunotherapy but still leaving it trailing a rival's drug.... Chinese authorities are probing a local unit of global catering giant Compass Group Plc over mouldy and expired food found at a private school served by the group and said it would inspect other schools around the city.... German drugmaker Merck KGaA might agree partnership deals to jointly develop two of its most promising experimental medicines with a rival as early as this year, but more likely in 2019, its drug research and development chief said on Sunday.... An AstraZeneca drug that blocks a cancer cell's ability to repair its genetic code greatly reduced the risk of ovarian cancer worsening in a phase III trial, underpinning its lead against two U.S. rivals in the same class.... Roche's entrectinib cancer pill was shown to shrink tumors in 57 percent of patients within a group that can only be identified via genetic profiling, as the Swiss drugmaker challenges an alliance of Bayer and Loxo Oncology in a new targeted treatment area.... An immunotherapy cocktail from Roche helped slow an aggressive type of breast cancer where new treatments have proven elusive, offering positive news for the Swiss drugmaker as it chases medicines produced by its rivals.... An experimental cancer drug that Novartis hopes will raise the profile of its oncology portfolio cut the risk of death or disease progression by more than a third in breast cancer patients with a hard-to-target gene mutation....